The effect of isoproterenol on phospholamban-deficient mouse hearts with altered thyroid conditions

Journal of Molecular and Cellular Cardiology

Volumn 31, Issue 9, 1999, Pages 1725-1737

  Brittsan, Angela G ^a   Kiss, Eva ^b   Edes, Istvan ^c   Grupp, Ingrid L ^a   Grupp, Gunter ^a   Kranias, Evangelia G ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF SZEGED   (Hungary)

^c UNIVERSITY OF DEBRECEN   (Hungary)

Author keywords

Ca2+ ATPpase; Isoproterenol; Knockout mice; Phospholamban; Sarcoplasmic reticulum; Thyroid hormone

Indexed keywords

ADENOSINE TRIPHOSPHATASE (CALCIUM); BETA ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; ISOPRENALINE; MYOSIN HEAVY CHAIN; PHOSPHOLAMBAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; HEART FUNCTION; HEART MUSCLE CONTRACTILITY; HEART MUSCLE RELAXATION; HEART WEIGHT; HYPERTHYROIDISM; HYPOTHYROIDISM; MOUSE; NONHUMAN; PRIORITY JOURNAL; THYROID FUNCTION;

EID: 0032879008     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmcc.1999.1010     Document Type: Article

References (37)

1. Arai M, Otsu K, MacLennan DH, Alpert NR, Periasamy M. Effect of thyroid hormone on the expression of mRNA encoding sarcopolasmic reticulum proteins. Circ Res. 69:1991;266-276.
2. Amidi M, Leon DF, DeGroot WJ, Kroetz FW, Leonard JJ. Effect of thyroid state on myocardial contractility and ventricular ejection rate in man. Circulation. 38:1968;229-239.
3. 1-adrenergic receptor gene in cultured ventricular myocytes. J Biol Chem. 266:1991;15863-15869.
4. 2+-ATPase in developing rat heart. Am J Physiol. 275:1998;H264-273.
5. Chu G, Luo W, Slack JP, Tilgmann C, Sweet WE, Spindler M, Saupe KW, Boivin GP, Moravec CS, Matlib MA, Grupp IL, Ingwall JS, Kranias EG. Compensatory mechanisms associated with the hyperdynamic function of phospholamban-deficient mouse hearts. Circ Res. 78:1996;1064-1076.
6. Dillmann WH. Biochemical basis of thyroid hormone action in the heart. Am J Med. 88:1990;626-630.
7. Grupp IL, Subramaniam A, Hewett TE, Robbins J, Grupp G. Comparison of normal, hypodynamic and hyperdynamic mouse hearts using isolated work-performing heart preparations. Am J Physiol. 34:1993;1401-1410.
8. Harrer JM, Kiss E, Kranias EG. Application of the immunoblot technique for quantitation of protein levels in cardiac homogenates. Biotechniques. 18:1995;995-997.
9. 2+ATPase gene. J Biol Chem. 269:1994;13021-13029.
10. Kaasik A, Paju K, Vetter R, Seppet EK. Thyroid hormones increase the contractility but suppress the effects of beta-adrenergic agonist by decreasing phospholamban expression in rat atria. Cardiovasc Res. 35:1997;106-112.
11. Kadambi VJ, Ponniah S, Harrer JM, Hoit BD, Dorn GW, Walsh RA, Kranias EG. Cardiac-specific overexpression of phospholamban alters calcium kinetics and resultant cardiomyocyte mechanics in transÍgenic mice. J Clin Invest. 97:1996;533-539.
12. 2+ATPase and decreasing phospholamban expression. J Mol Cell Cardiol. 26:1994;1145-1154.
13. 2+transport and myocardial relaxation. Circ Res. 75:1994;245-251.
14. Kiss E, Edes I, Sato Y, Luo W, Liggett SB, Kranias EG. β-Adrenergic regulation of cAMP and protein phosphorylation in phospholamban-knockout mouse hearts. Am J Physiol. 272:1997;H785-H790.
15. Kiss E, Brittsan AG, Edes I, Grupp IL, Grupp G, Kranias EG. Thyroid hormone-induced alterations in phospholamban-deficient mouse hearts. Circ Res. 83:1998;608-613.
16. Korecky B, Zak R, Schwartz K, Aschenbrenner V. Role of thyroid hormone in regulation of isomyosin composition contractility, and size of heterotopically isotransplanted rat heart. Circ Res. 60:1987;824-830.
17. Koss KL, Kranias EG. Phospholamban: A prominent regulator of myocardial contractility. Circ Res. 79:1996;1059-1063.
18. Kranias EG, Garvey JL, Srivastava RD, Solaro RJ. Phosphorylation and functional modifications of sarcoplasmic reticulum and myofibrils in isolated rabbit hearts stimulated with isoprenaline. Biochem J. 226:1985;113-121.
19. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 227:1970;680-685.
20. Levine MA, Feldman AM, Robishaw JD, Ladenson PW, Ahn TG, Moroney JF, Smallwood PM. Influence of thyroid hormone status on expression of genes encoding G protein subunits in the rat heart. J Biol Chem. 265:1990;3553-3560.
21. 2+-ATPase in failing and nonfailing human hearts. Cardiovasc Res. 31:1996;625-631.
22. 2+-ATPase activity in guinea pig ventricles. J Biol Chem. 260:1983;4516-4525.
23. Luo W, Grupp IL, Harrer J, Ponniah S, Grupp G, Duffy JJ, Doetschman T, Kranias EG. Targeted ablation of the phospholamban gene is associated with markedly enhanced myocardial contractility and loss of β-agonist stimulation. Circ Res. 75:1994;401-409.
24. 2+channels in mouse ventricular myocytes. Am J Physiol. 272:1997;H606-612.
25. Meyer M, Schillinger W, Pieske B, Houbarsch C, Heilmann C, Posival H, Kuwajima G, Mikoshiba K, Just H, Hasenfuss G. Alterations of sarcoplasmic reticulum proteins in failing human dilated cardiomyopathy. Circulation. 92:1995;778-784.
26. Morkin E, Flink IL, Goldman S. Biochemical and physiological effects of thyroid hormones on cardiac performance. Prog Cardiovasc Dis. 25:1983;435-464.
27. 2+-transporting ATPase, phospholamban and calsequestrin levels in nonfailing and failing human myocardium. Circulation. 90:1994;653-657.
28. Ng WA, Grupp IL, Subramaniam A, Robbins J. Cardiac myosin heavy chain mRNA expression and myocardial function in the mouse heart. Circ Res. 68:1991;1742-1750.
29. Orlowski J, Lingrel JB. Thyroid and glucocorticoid hormones regulate the expression of multiple Na, K-ATPase genes in cultured neonatal rat cardiac myocytes. J Biol Chem. 265:1990;3462-3470.
30. Santana LF, Kranias EG, Lederer WJ. Calcium sparks and excitation-contraction coupling in phospholamban-deficient mouse ventricular myocytes. J Physiol. 503:1997;21-29.
31. Schwartz K, Lecarpentier Y, Martin JL, Lompre AM, Mercadier JJ, Swynghedauw B. Myosin isoenzymic distribution correlates with speed of myocardial contraction. J Mol Cell Cardiol. 13:1981;1071-1075.
32. 2+-ATPase activity of cardiac sarcoplasmic reticulum from dilated cardiomyopathy patients compared with patients with nonfailing hearts. Circulation. 92:1995;3220-3228.
33. 2+-Sensitivity of SERCA 2a in failing human myocardium due to reduced serin-16 phospholamban phosphorylation. J Mol Cell Cardiol. 31:1999;379-491.
34. 2+transporters by thyroid hormone. Mol and Cell Biochem. 129:1993;145-159.
35. 2+/calmodulin dependent protein kinase. J Biol Chem. 269:1994;26492-26496.
36. Xu, A, Hawkins, C, Narayanan, N, 1993, Phosphorylation and activation of the Ca-pumping ATPase of cardiac sarcoplasmic reticulum by Ca/calmodulin-dependent protein kinase, J Biol Chem, 268, 8394, 8397, J Biol Chem, 269, 26492, 26496.
37. Xu, A, Hawkins, C, Narayanan, N, 1993, Phosphorylation and activation of the Ca-pumping ATPase of cardiac sarcoplasmic reticulum by Ca/calmodulin-dependent protein kinase, J Biol Chem, 268, 8394, 8397, J Biol Chem, 269, 26492, 26496.